About VeloGene

Articles & Resources

Welcome to our articles and resource page, a comprehensive knowledge library built for researchers working with mouse models and gene editing mice. We have organized four independent columns for different research topics, namely “Rare Diseases ‘Matter’“, “Preclinical Frontiers“, “Micipedia“, and “Script Lab“. Each section delivers targeted content to match your research needs:

  1. Rare Diseases “Matter” shares insights on rare disease mouse models;
  2. Preclinical Frontiers covers cutting-edge preclinical research powered by gene editing mice;
  3. Micipedia acts as an encyclopedia of basic mouse strain and model background knowledge;
  4. Script Lab provides thorough dissection of academic papers featuring custom mouse models.

All resources are designed to help you grasp genome editing techniques, model selection strategies and experimental optimization solutions for your in vivo research projects.

Rare Diseases Matter

We are focusing on what and how mouse models help with the rare diseases drug development
Read Column

Preclinical Frontier

We are focusing on the mouse models empowering the drug development
Read Column

Micipedia

Introduction of different types of mice and knowledge about mouse models
Read Column

Script Lab:
Paper Breakdown

We are studying and dissecting papers and article
Read Column
DateAuthorTitleJournalLink
2020.11.20Dr. Wu GuangmingRapid generation of ACE2 humanized inbred mouse model for COVID-19 with tetraploid complementationNational Science ReviewRead
2024.01.02Dr. Wu GuangmingHighly cooperative chimeric super-SOX induces naive pluripotency across speciesCell Stem CellRead
2019.12.05Dr. Wu GuangmingExcluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCsCell Stem CellRead
2014.3.26Dr. Wu GuangmingNuclear reprogramming by interphase cytoplasm of two-cell mouse embryosNatureRead
2010.12.15Dr. Wu GuangmingInitiation of trophectoderm lineage specification in mouse embryos is independent of Cdx2 DEVELOPMENT AND STEM CELLSRead
2010.01.10Dr. Wu GuangmingEfficient Derivation of Pluripotent Stem Cells from siRNA-Mediated Cdx2-Deficient Mouse EmbryosStem Cell DevelopmentRead

IP Assurance

At VeloGene, we operate on a strict fee-for-service model. All intellectual property (IP) and materials created for your project are 100% yours. We take every measure to safeguard your IP, ensuring no vectors, ES cells, or mouse lines are retained or resold to third parties. This way, you can focus on your research with complete peace of mind.